Amylyx Pharmaceuticals Inc (AMLX)
1.835
+0.02
(+0.82%)
USD |
NASDAQ |
May 16, 16:00
1.835
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Price: 1.835 for May 16, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 16, 2024 | 1.83 | 1.85 | 1.79 | 1.83 | 775447.0 |
May 15, 2024 | 1.90 | 1.94 | 1.82 | 1.82 | 1.096M |
May 14, 2024 | 1.83 | 1.94 | 1.83 | 1.87 | 1.572M |
May 13, 2024 | 1.80 | 1.85 | 1.75 | 1.82 | 1.351M |
May 10, 2024 | 1.88 | 1.992 | 1.75 | 1.755 | 1.590M |
May 09, 2024 | 1.84 | 1.90 | 1.73 | 1.89 | 3.285M |
May 08, 2024 | 1.96 | 1.99 | 1.89 | 1.93 | 1.515M |
May 07, 2024 | 1.99 | 2.015 | 1.94 | 1.97 | 900905.0 |
May 06, 2024 | 2.04 | 2.050 | 1.94 | 1.99 | 1.527M |
May 03, 2024 | 2.05 | 2.13 | 2.00 | 2.03 | 1.478M |
May 02, 2024 | 1.96 | 2.05 | 1.93 | 2.00 | 1.911M |
May 01, 2024 | 1.82 | 1.975 | 1.80 | 1.93 | 1.803M |
Apr 30, 2024 | 1.92 | 1.97 | 1.81 | 1.81 | 1.883M |
Apr 29, 2024 | 1.79 | 1.98 | 1.76 | 1.90 | 2.101M |
Apr 26, 2024 | 1.79 | 1.84 | 1.70 | 1.76 | 5.218M |
Apr 25, 2024 | 1.87 | 1.91 | 1.76 | 1.78 | 2.479M |
Apr 24, 2024 | 1.97 | 1.99 | 1.87 | 1.88 | 1.742M |
Apr 23, 2024 | 1.97 | 2.02 | 1.94 | 1.95 | 1.471M |
Apr 22, 2024 | 1.90 | 2.025 | 1.90 | 1.98 | 1.556M |
Apr 19, 2024 | 1.98 | 2.02 | 1.85 | 1.87 | 2.504M |
Apr 18, 2024 | 2.01 | 2.030 | 1.955 | 1.98 | 1.034M |
Apr 17, 2024 | 2.04 | 2.08 | 1.99 | 2.00 | 1.734M |
Apr 16, 2024 | 2.07 | 2.07 | 1.98 | 2.01 | 2.158M |
Apr 15, 2024 | 2.10 | 2.14 | 1.99 | 2.07 | 3.707M |
Apr 12, 2024 | 2.28 | 2.29 | 2.07 | 2.10 | 2.825M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.755
Minimum
May 10 2024
40.93
Maximum
Jan 27 2023
21.73
Average
21.58
Median
Price Benchmarks
Cassava Sciences Inc | 21.56 |
iRhythm Technologies Inc | 98.72 |
Bristol-Myers Squibb Co | 44.11 |
Moderna Inc | 132.65 |
ACADIA Pharmaceuticals Inc | 14.85 |
Price Related Metrics
PS Ratio | 0.3187 |
Price to Book Value | 0.3836 |
Price to Free Cash Flow | 8.214 |
Earnings Yield | -58.47% |
Market Cap | 124.79M |